drugset / Trial / NCT05266534

The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic Tourniquets

NCT05266534

Recruiting 162 enrolled Wael Elbanna Clinic
RandomizedParallel-groupTriple-blindTreatment

Summary

For gynecologists, reaching a conclusion about the efficacy of intramyometrial Terlipressin injection versus intramyometrial Carbetocin injection on hemoglobin level and decreasing blood loss in women undergoing open myomectomy that would influence the clinical decision and best practice. Besides enriching the clinical evidence in open myomectomy without using haemostatic tourniquets. For society, our conclusion and recommendation shall maximize the benefits and managing the benefits of the technique used. Moreover, providing more information for women undergoing open myomectomy without using haemostatic tourniquets.

Timeline

Start
2021-12-30
Primary completion
2024-06-30
Completion
2026-12-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Carbetocin Peptide Other
Comparator Terlipressin Peptide Other

Indications